Ajcc prostate cancer staging 8th edition pdf

Abstract

Introduction

The American Joint Committee on Cancer (AJCC) tumor, node, metastasis classification system (TNM) staging manual has been updated and provides more specified stage grouping for prostate cancer (PCa). We aimed to validate the updated AJCC stage groups for PCa using a radical prostatectomy (RP) cohort.

Patients and Methods

We analyzed the data of 3032 patients previously treated with RP for localized PCa. We stratified patients into stage groups according to the 8th edition of the AJCC manual and compared biochemical recurrence (BCR)-free survival using Kaplan-Meier analyses.

Results

There were 217 patients in stage group I, 33 in IIA, 1101 in IIB, 535 in IIC, 129 in IIIA, 781 in IIIB, and 236 in IIIC. There were no significant differences in BCR-free survival between stage groups IIC and IIIA (P = .875). Subsequently, the low–Gleason score (GS) IIIA subgroup (GS ≤ 3 + 4, P = .025) showed superior BCR-free survival than the IIC group, and the high-GS IIIA subgroups (GS ≥ 4 + 3, P = .004) showed a poorer BCR-free survival than the IIC group. Furthermore, there were no significant differences between groups I and IIA (P = 330) and between groups IIA and IIB (P = .942). Our new staging system provided a better ability to discriminate the prognosis of each group. However, our study has several limitations, such as retrospective design, relatively short follow-up period, and need for further validation.

Conclusion

The current AJCC prognostic groups show some contradictory results, particularly concerning prognosis of the IIC and IIIA groups. We suggest that GS be given more weight than serum prostate-specific antigen level in stage group stratification.

Keywords

• AJCC prognosis group
• Biochemical recurrence
• Prostate cancer
• Prostate-specific antigen
• Prostatectomy

To read this article in full you will need to make a payment

References

1. • Torre L.A.
   • Bray F.
   • Siegel R.L.
   • et al.

   Global cancer statistics, 2012.

   CA Cancer J Clin. 2015; 65: 87-108
2. • Ryerson A.B.
   • Eheman C.R.
   • Altekruse S.F.
   • et al.

   Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer.

   Cancer. 2016; 122: 1312
3. • Penney K.L.
   • Stampfer M.J.
   • Jahn J.L.
   • et al.

   Gleason grade progression is uncommon.

   Cancer Res. 2013; 73: 5163
4. • Cooperberg M.R.
   • Cowan J.
   • Broering J.M.
   • et al.

   High-risk prostate cancer in the United States, 1990-2007.

   World J Urol. 2008; 26: 211
5. • Klotz L.
   • Zhang L.
   • Lam A.
   • et al.

   Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.

   J Clin Oncol. 2010; 28: 126
6. • Ha J.Y.
   • Shin T.J.
   • Jung W.
   • et al.

   Updated clinical results of active surveillance of very-low-risk prostate cancer in Korean men: 8 years of follow-up.

   Investig Clin Urol. 2017; 58: 164
7. • Prensner J.R.
   • Rubin M.A.
   • Wei J.T.
   • et al.

   Beyond PSA: The next generation of prostate cancer biomarkers.

   Sci Transl Med. 2012; 4: 127rv3
8. • Neupane S.
   • Steyerberg E.
   • Raitanen J.
   • et al.

   Prognostic factors of prostate cancer mortality in a Finnish randomized screening trial.

   Int J Urol. 2018; 25: 270-276
9. • Sartori D.A.
   • Chan D.W.

   Biomarkers in prostate cancer: what's new?.

   Curr Opin Oncol. 2014; 26: 259
10. • Buyyounouski M.K.
    • Choyke P.L.
    • McKenney J.K.
    • et al.

    Prostate cancer—major changes in the American Joint Committee on Cancer 8th edition cancer staging manual.

    CA Cancer J Clin. 2017; 67: 245
11. • Abdel-Rahman Omar

    Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; a time to sub-classify stage IV?.

    PLoS One. 2017; 12: e0188450
12. • Buyyounouski M.K.
    • Choyke P.L.
    • Kattan M.W.
    • et al.

    Prostate.

    in: Amin M.B. Edge S.B. Greene F.L. AJCC Cancer Staging Manual. 8th ed. Springer, New York, NY2017: 715
13. • Epstein J.I.
    • Allsbrook Jr., W.C.
    • Amin M.B.
    • et al.
    • ISUP Grading Committee

    The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma.

    Am J Surg Pathol. 2005; 29: 1228
14. • Greene F.L.
    • Page D.L.
    • Fleming I.D.
    • et al.

    AJCC Cancer Staging Manual.

    6th ed. Springer-Verlag, New York, NY2002
15. • Xiao W.J.
    • Zhu Y.
    • Dai B.
    • et al.

    Evaluation of the major changes in 8th edition of the American Joint Committee on Cancer pathological staging for prostate cancer treated with prostatectomy.

    PLoS One. 2017; 12: e0187887
16. • Bhindi B.
    • Karnes R.J.
    • Rangel L.J.
    • et al.

    Independent validation of the American Joint Committee on Cancer 8th edition prostate cancer staging classification.

    J Urol. 2017; 98: 1286
17. • Abdel-Rahman O.

    Validation of American Joint Committee on Cancer 8th staging system among prostate cancer patients treated with radical prostatectomy.

    Ther Adv Urol. 2017; 10: 35
18. • Epstein J.I.
    • Zelefsky M.J.
    • Sjoberg D.D.
    • et al.

    A contemporary prostate cancer grading system: a validated alternative to the Gleason score.

    Eur Urol. 2016; 69: 428
19. • Resnick M.J.
    • Koyama T.
    • Fan K.H.
    • et al.

    Long-term functional outcomes after treatment for localized prostate cancer.

    N Engl J Med. 2013; 368: 436
20. • Wilt T.J.
    • Brawer M.K.
    • Jones K.M.
    • et al.

    Radical prostatectomy versus observation for localized prostate cancer.

    N Engl J Med. 2012; 367: 203
21. • D'Amico A.V.
    • Whittington R.
    • Malkowicz S.B.
    • et al.

    Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

    JAMA. 1998; 280: 969
22. • Epstein J.I.
    • Egevad L.
    • Amin M.B.
    • et al.

    The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: definition of grading patterns and proposal for a new grading system.

    Am J Surg Pathol. 2016; 40: 244

Article Info

Related Articles